UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
October
5, 2017
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
|
001-35024 |
87-0500306 |
|
|
(Commission File No.) |
(IRS Employer Identification |
|
|
|
Number) |
|
3838 West Parkway Boulevard |
|
(Address of principal executive offices, Zip Code) |
|
Registrant’s telephone number, including area code: (801) 954-7100 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2).
Emerging Growth Company ⃞
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financialaccounting standards provided pursuant to Section 13(a) of the Exchange Act. ⃞
Item 5.02, Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Effective as of October 5, 2017, the Board of Directors of USANA Health Sciences, Inc. (the “Company”) acted unanimously to appoint Mr. J. Scott Nixon as an additional director of the Company, for an initial term expiring at the Company’s 2018 Annual Meeting of Shareholders. Mr. Nixon has not been appointed to any Committees of the Board of Directors at this time.
Mr. Nixon, a certified public accountant, retired in 2015 as a partner with PricewaterhouseCoopers LLP (PwC) where he spent over 31 years in various roles including Office Managing Partner and engagement partner over public and private companies in many industries. His career involved providing audit and business advisory services. Mr. Nixon was involved in numerous complex filings with the Securities and Exchange Commission on behalf of his clients. In 2007, Mr. Nixon returned from a four-year assignment in São Paulo, Brazil where he represented various interests of the PwC global firm to the 18-member firms in South and Central America, and led the implementation and compliance of the Sarbanes-Oxley requirements in those countries. Mr. Nixon has served as a member of the Board of Directors of ProLung, Inc. since November 2016. He also serves on several boards of directors for private and non-profit companies, including Deseret Trust Company as a member of the Audit and Executive Committees since 2015 and Utah State University Board of Trustees, as Chairman of the Audit Committee since 2011. Mr. Nixon is currently a Trustee, Vice Chairman and a member of the Executive Committee of MountainWest Capital Network and is a National Association of Corporate Directors (NACD) Governance Fellow. He holds both a BA and Master of Accounting from Utah State University.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 Press release issued by USANA Health Sciences, Inc. dated October 5, 2017 (furnished herewith).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
USANA HEALTH SCIENCES, INC. |
||
|
|
||
|
|
||
|
|
|
By: /s/ Douglas Hekking |
|
G. Douglas Hekking, Chief Financial Officer |
||
|
|
||
|
Date: |
October 5, 2017 |
Exhibit 99.1
USANA Health Sciences Announces Appointment of J. Scott Nixon to Board of Directors
SALT LAKE CITY--(BUSINESS WIRE)--October 5, 2017--USANA Health Sciences, Inc. (NYSE: USNA) today announced the appointment of J. Scott Nixon to the company’s board of directors effective October 5, 2017. Mr. Nixon joins the board as an independent director and brings a wealth of accounting, finance, and corporate strategy expertise. The USANA board now has eight members, five of whom are independent.
Myron W. Wentz, Ph.D., Chairman of the Board, commented, “I’m very pleased to welcome Scott Nixon to our board. He brings significant finance, accounting, and industry experience – with over three decades in international and domestic audit and business advisory services across a variety of industries, including direct selling – which will provide tremendous value to USANA.”
Mr. Nixon commented, “Having spent several years working directly with USANA, I am very familiar with the company’s business and the strong corporate values and commitment to health and nutrition that make it a leader in its industry. I am honored to accept a seat on the company’s board of directors and look forward to contributing to USANA’s future success.”
About Scott Nixon
Mr. Nixon, a certified public accountant, retired in 2015 as a partner with PricewaterhouseCoopers LLP (“PwC”) where he spent over 31 years in various roles including office managing partner and engagement partner over public and private companies in many industries. His career involved providing audit and business advisory services. Mr. Nixon was involved in numerous complex filings with the Securities and Exchange Commission on behalf of his clients. In 2007, Mr. Nixon returned from a four-year assignment in São Paulo, Brazil where he represented various interests of the PwC global firm to the 18 member firms in South and Central America, and led the implementation of the Sarbanes-Oxley requirements in those countries.
Mr. Nixon serves on several boards of directors, including: (i) ProLung, Inc., where he also serves as Chairman of the Audit Committee and a member of the Compensation Committee; (ii) Deseret Trust Company, where he also serves as a member of the Audit and Executive Committees; (iii) Utah State University Board of Trustees, where he also serves as Chairman of the Audit Committee; and (iv) two other nonprofit boards of directors. Mr. Nixon is a National Association of Corporate Directors (NACD) Governance Fellow, the highest standard of credentialing for directors and governance professionals. He holds both a Bachelor of Arts and Master of Accounting from Utah State University.
About USANA
USANA develops and manufactures high-quality nutritional supplements, healthy foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia and Indonesia. More information on USANA can be found at www.usana.com.
CONTACT:
USANA Health Sciences, Inc.
Investors contact:
Patrique
Richards, 801-954-7961
Investor Relations
investor.relations@us.usana.com
or
Media
contact:
Dan Macuga, 801-954-7280
Public Relations